Related Experiment Videos
Premedicating children for painful invasive procedures.
Summary
Pediatric oncology specialists commonly use premedication for children undergoing painful procedures like bone marrow aspirations and lumbar punctures. Most believe these medications are essential to manage procedural anxiety and pain in pediatric cancer patients.
Area of Science:
- Pediatric Oncology
- Pain Management
- Child Psychology
Background:
- Children with cancer frequently experience significant anxiety during invasive procedures.
- Pain, fear, and anxiety associated with procedures can lead to adverse psychological and developmental effects.
- Inadequate pharmacological management, due to myths and lack of knowledge, contributes to underdosing and limited medication use.
Purpose of the Study:
- To explore the attitudes and perceptions of oncology physicians and nurses regarding premedication for pediatric cancer patients before invasive procedures.
- To identify common premedications and assess the perceived necessity of pre-procedural medication in pediatric oncology.
Main Methods:
- Survey or questionnaire-based study.
- Exploration of healthcare professionals' (oncology physicians and nurses) attitudes and perceptions.
- Focus on premedication practices for pediatric cancer patients undergoing procedures like bone marrow aspirations (BMAs) and lumbar punctures (LPs).
Main Results:
- Most pediatric oncology specialists administer premedication to children before invasive procedures.
- Commonly used premedications include Versed, Demerol, Phenergan, Thorazine, chloral hydrate, Ativan, fentanyl, and Xylocaine.
- A majority of specialists believe premedication is necessary for procedures such as BMAs and LPs.
Conclusions:
- Pediatric oncology specialists generally support and utilize premedication for children undergoing painful procedures.
- There is a perceived necessity for pharmacological interventions to mitigate anxiety and pain in pediatric cancer patients.
- Further investigation into standardized protocols for premedication in pediatric oncology is warranted given the existing controversies.